These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28087107)

  • 1. Establishment of the 2nd Korean national biological reference standard for blood coagulation factor VIII:C concentrate.
    Lee N; Seo JS; Kim JO; Ban SJ
    Biologicals; 2017 May; 47():59-63. PubMed ID: 28087107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A collaborative study to establish a Korean Standard for factor VIII:C concentrate.
    Kang HN; Kim SN; Lee SH; Hong SH
    Thromb Res; 2004; 113(3-4):261-7. PubMed ID: 15140591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calibration of human coagulation factor VIII concentrate Ph. Eur. BRP Batch 4 for use in potency assays.
    Raut S; Costanzo A; Daniels S; Heath A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):1-29. PubMed ID: 21144486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.
    Kirschbaum N; Wood L; Lachenbruch P; Weinstein M; Daas A; Rautmann G; Spieser JM; Buchheit KH
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):31-64. PubMed ID: 12448031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a procedure for potency assessing of a high purity factor VIII concentrate--comparison of different factor VIII coagulant assays and effect of prediluent.
    Mazurier C; Parquet-Gernez A; Goudemand M
    Thromb Haemost; 1990 Oct; 64(2):251-5. PubMed ID: 2125374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII:C activity in hemophilic plasma using one-stage clotting assays.
    Ingerslev J; Jankowski MA; Weston SB; Charles LA;
    J Thromb Haemost; 2004 Apr; 2(4):623-8. PubMed ID: 15102018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization, and recommendations.
    Barrowcliffe TW; Raut S; Sands D; Hubbard AR
    Semin Thromb Hemost; 2002 Jun; 28(3):247-56. PubMed ID: 12098084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative study for the establishment of replacement batches for human coagulation factor IX concentrate reference standards.
    Gray E; Pickering W; Hockley J; Rigsby P; Weinstein M; Terao E; Buchheit KH
    Pharmeuropa Bio; 2008 Dec; 2008(1):19-30. PubMed ID: 19220978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency estimation of recombinant factor VIII: effect of assay method and standard.
    Hubbard AR; Bevan SA; Weller LJ
    Br J Haematol; 2001 May; 113(2):533-6. PubMed ID: 11380427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter pharmacokinetic study of the B-domain deleted recombinant factor VIII concentrate using different assays and standards.
    Morfini M; Cinotti S; Bellatreccia A; Paladino E; Gringeri A; Mannucci PM;
    J Thromb Haemost; 2003 Nov; 1(11):2283-9. PubMed ID: 14629459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calibration of the Ph. Eur. human coagulation Factor VIII concentrate BRP batch 5.
    Raut S; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2017; 2017():1-11. PubMed ID: 28279252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calibration of the WHO 5th IS for Blood Coagulation Factor IX, Concentrate and Ph. Eur. Human Coagulation Factor IX Concentrate Biological Reference Preparation Batch 3 and investigation of the suitability of an IS as potency standard for purified full-length recombinant FIX.
    Gray E; Hogwood J; Dougall T; Rigsby P; Matejtschuk P; Terao E
    Pharmeur Bio Sci Notes; 2021; 2021():26-68. PubMed ID: 33783349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2.
    Dodt J; Costanzo A; Daas A; Hunfeld A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):31-8. PubMed ID: 20223188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of the WHO hearing on the development of product-specific reference materials for coagulation factor VIII and factor IX products.
    Ovanesov MV; Williams SC; Nübling CM; Dodt J; Hilger A; Maryuningsih Y; Gray E
    Biologicals; 2020 Sep; 67():88-93. PubMed ID: 32847723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A collaborative study to establish the 6th International Standard for factor VIII concentrate.
    Raut S; Heath AB; Barrowcliffe TW
    Thromb Haemost; 2001 Jun; 85(6):1071-8. PubMed ID: 11434687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation profiles of factor VIII in concentrates reflect one-stage/chromogenic potency discrepancies.
    Hubbard AR; Weller LJ; Bevan SA
    Br J Haematol; 2002 Jun; 117(4):957-60. PubMed ID: 12060137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of the human coagulation factor VII concentrate European Pharmacopoeia biological reference preparation batch 1.
    Dodt J; Hunfeld A; Daas A; Buchheit KH
    Pharmeuropa Bio; 2006 Nov; 2006(1):15-22. PubMed ID: 17270128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study.
    Hillarp A; Bowyer A; Ezban M; Persson P; Kitchen S
    Haemophilia; 2017 May; 23(3):458-465. PubMed ID: 28198071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calibration of the Ph. Eur. human coagulation Factor VIII Concentrate BRP batch 6.
    Raut S; Le Tallec D; Costanzo A
    Pharmeur Bio Sci Notes; 2021; 2021():88-100. PubMed ID: 33973517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardisation of factor VIII--V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand factor activities in plasma.
    Heath AB; Barrowcliffe TW
    Thromb Haemost; 1992 Aug; 68(2):155-9. PubMed ID: 1412160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.